Skip to main content

OSLER-WEBER-RENDU DISEASE

Tracking # 20-813897

$99999.00

There are no ratings for this course

Learn more
CE Broker Reporting Reported automatically
Method Computer-Based Training

Course overview

HEREDITARY HEMORRHAGIC TELANGIECTASIA (HHT) IS ALSO KNOWN AS OSLER–WEBER–RENDU DISEASE. IT IS AN AUTOSOMAL DOMINANT DISORDER CHARACTERIZED BY MULTIPLE MUCOCUTANEOUS TELANGIECTASIAS. THESE TELANGIECTASIAS REPRESENT SMALL ARTERIO-VENOUS MALFORMATIONS THAT FREQUENTLY TEND TO BLEEDS CAUSING THE PATIENT A SIGNIFICANT AMOUNT OF DISTRESS IN THEIR DAILY LIVES. PATIENTS TYPICALLY PRESENT WITH NOSE BLEEDS, GASTROINTESTINAL (GI) BLEEDS, AND IRON DEFICIENCY ANEMIA. THIS ACTIVITY REVIEWS THE PATHOPHYSIOLOGY OF OSLER WEBER RENDU SYNDROME AND HIGHLIGHTS THE ROLE OF THE INTERPROFESSIONAL TEAM IN ITS MANAGEMENT.

Subject areas

This course counts toward the state boards and subject areas below.

Bahamas Medical Council

Specialty Medical Practitioner

1h General Medicine

Louisiana State Board of Medical Examiners - Physicians & Surgeons

Physician & Surgeon

1h Category I CME

Mississippi State Board of Medical Licensure

Medical Doctor

1h AMA Category I

Physician Assistant

1h AMA Category I

State Medical Board of Ohio

Doctor of Medicine

1h AMA Category I